Czech's reject Baxter flu vaccine
The Czech Republic will no longer purchase the H1N1 flu vaccine from Baxter International.
The Czech Republic will no longer purchase the H1N1 flu vaccine from Baxter International. The Czech Health Ministry has reportedly explained that it is stopping talks with Baxter due to the firm's inability to guarantee that the vaccine is safe. “It is a pity, but unfortunately at the moment when we accepted the bids, Baxter was unable to confirm that it will deliver a registered vaccine,” commented Health Minister Dana Juraskova on the Czech news site tn.nova.cz.
The Czech Republic originally planned to purchase vaccines for 60% of its population, but has now revised its plans and will purchase vaccines for just 25% of the population with the addition of Tamiflu and Relenza antivirotics for the same number. To date, more than 60 Czechs have been diagnosed with swine flu, with no fatalities being registered.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
